Report updated Jun 30, 2026
Pill Reminder MyTherapy
For individuals managing chronic conditions like diabetes, hypertension, or ADHD, and caregivers coordinating treatment for others.
Pill Reminder MyTherapy is an established medical app that is completely free. With a 4.8/5 rating from 7.9K reviews, it shows polarized user reception. Users particularly appreciate reliable medication reminders provide essential support for daily health management routines, though inconsistent notification delivery post-update causes critical failure in medication adherence remains a common concern.
What is Pill Reminder MyTherapy?
MyTherapy is a medication reminder and health tracking app for individuals managing chronic conditions, available on iOS and Android.
Users hire MyTherapy to manage complex medication schedules and health metrics in one interface, reducing the cognitive load of treatment adherence.
Current Momentum
v3.266
- Ships minor stability and bug fixes.
- Maintains high-frequency notification reminder loop.
Active Nemesis
Shotsy GLP-1 Tracker
By Shotsy
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Flexible alarm system for medication doses and prescription renewal notifications
Document and rotate injection sites to support treatment safety
Automatic integration with Apple Health for weight, steps, and water intake data
Exportable data summaries for physician consultation
Visual tracking of daily medication adherence progress
How much does it cost?
- Free access to all medication tracking and health reporting features
The app operates as a free tool, utilizing ISO 13485 and ISO 27001 certifications to establish trust and user acquisition.
Who Built It?
Supporting patients in managing complex medication regimens through structured tracking and personalized reminders.
Portfolio
1
Apps
Explore the full smartpatient report
Portfolio breakdown, audience, momentum, and every app published by smartpatient.
What do users think recently?
High confidence · Latest 140 of 1.1K total reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate reliable medication reminders provide essential support for daily health management routines and versatile tracking features allow users to monitor symptoms and measurements alongside medications, but report inconsistent notification delivery post-update causes critical failure in medication adherence and intrusive advertising and subscription pressure degrade the user experience for long-term supporters.
What Users Love
What Frustrates Users
What Users Want
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Pill Reminder MyTherapy?
How's The Medical Market?
MyTherapy operates as a free, ad-supported tool within the Medical category, currently holding a #56 Grossing position in the US. The app leverages ISO 13485 and ISO 27001 certifications to establish trust, positioning itself as a clinical-grade alternative to basic pill trackers.
How does it evolve in the Medical market?
MyTherapy holds a #56 Grossing position in the US Medical category. The gap between its high utility and recent sentiment decline signals that monetization friction is currently outpacing its discovery advantage.
Rank progression
184 active rankings tracked — 30-day window
Which niche is Pill Reminder MyTherapy in?
to track medication adherence and health metrics
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
Shotsy directly competes for the high-intent medication management audience by focusing on specialized tracking for GLP-1 users, a rapidly growing segment of the medication adherence market.
Differentiators
- Provides predictive medication level modeling which helps users visualize drug efficacy over time
- Deep Apple Health integration allows for automated syncing of weight and activity data points
- Specialized focus on GLP-1 injection schedules offers a more tailored UX than generic trackers
Head to head
MyTherapy should prioritize adding specialized medication-level modeling to prevent losing the high-value GLP-1 user segment to niche competitors.
Contenders(4)
WellView competes by focusing on the financial and logistical aspects of prescription management, specifically for mail-order pharmacy users.
Differentiators
- Integrated drug cost search tools help users optimize their pharmacy spending in real-time
- Mail-order transfer capabilities streamline the fulfillment process for chronic medication maintenance
This app targets the same health-conscious demographic by focusing on visual data representation and trend analysis for glucose management.
Differentiators
- Dedicated A1C tracking modules provide long-term health insights that simple pill reminders lack
- Visual progress reporting offers immediate gratification through charts that motivate consistent daily logging
Walmart competes by integrating medication reminders with the logistical fulfillment of prescriptions, creating a closed-loop pharmacy experience.
Differentiators
- Integrated prescription management allows users to order refills directly within the reminder workflow
- Physical retail footprint provides a tangible service advantage for pharmacy pickup and logistics
This app competes by offering deep integration with hardware peripherals, appealing to users who require precise, automated data logging for chronic condition management.
Differentiators
- Direct Bluetooth connectivity to medical hardware automates data entry, reducing manual logging friction
- Advanced remote monitoring features enable seamless data sharing with healthcare providers for clinical oversight
Same space(3)
This peer competes by offering clinical-grade AI coaching, positioning itself as a comprehensive health management platform rather than just a reminder tool.
Differentiators
- Clinical-grade AI coaching offers personalized health advice based on aggregated patient data
- Device-agnostic data synchronization ensures compatibility with a wide range of third-party health hardware
Libre competes by providing a proprietary ecosystem for continuous glucose monitoring, effectively locking users into their hardware-software loop.
Differentiators
- Real-time glucose monitoring provides continuous data streams that outperform static manual logging
- LibreLinkUp enables a robust social and clinical support network for caregivers and doctors
This app serves as a specialized peer for users requiring direct hardware control and remote monitoring of insulin delivery systems.
Differentiators
- Remote bolus delivery functionality provides critical utility that standard reminder apps cannot match
- Secondary pump display turns the smartphone into a vital medical interface for insulin management
Compare Pill Reminder MyTherapy against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Pill Reminder MyTherapy
Strengths to defend, gaps to attack
Core Strengths
- ISO 13485/27001 certification establishes trust-based barrier
- Cross-metric health logging creates central hub reliance
- Streak-based gamification drives daily habit formation
Critical Frictions
- Notification unreliability post-update erodes core utility
- Intrusive ad-insertion alienates legacy user base
- Lack of multi-device cloud sync limits data security
Growth Levers
- B2B integration with healthcare provider workflows
- Wearable-first expansion for Apple Watch users
- Specialized medication-level modeling for GLP-1 users
Market Threats
- Niche trackers siphoning high-value chronic condition users
- Hardware-linked apps locking users into proprietary ecosystems
- Minimalist entrants reducing friction for casual users
What are the next best moves?
Audit notification delivery logic because post-update failures are the top-cited safety concern → restore user trust
Notification reliability is the #1 complaint theme and a critical safety failure.
Trade-off: Pause the ad-inventory expansion sprint — notification stability has 5x the churn impact.
Ship cloud synchronization because data loss is the top-requested feature → improve long-term retention
Cloud sync is the most requested feature in user feedback.
Trade-off: Delay the custom activity labels feature — cloud sync is a higher-value retention lever.
Pivot ad-placement strategy because intrusive ads are alienating legacy users → reduce churn
Sentiment analysis shows ad-intrusiveness is a primary driver of negative reviews.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The app's high rating is a lagging indicator; the current technical instability and monetization friction are creating a 'trust debt' that will likely trigger a sharp rating decline in the next quarter.
Feature Gaps vs Competitors
- Predictive medication level modeling (available in Shotsy but missing here)
- Direct Bluetooth medical hardware connectivity (available in MedM but missing here)
- Integrated drug cost search tools (available in WellView but missing here)
Key Takeaways
- Prioritize notification reliability to prevent churn of chronic-condition users who rely on the app for safety.
- Pivot monetization strategy to reduce ad-intrusiveness, as legacy user alienation is currently driving negative sentiment.
- Develop cloud-sync functionality to address the #1 requested feature and improve long-term data retention.
MyTherapy maintains a strong category lead through essential medication-adherence tools, but the recent decline in notification reliability and intrusive monetization creates a churn risk, so the PM must prioritize technical stability over ad-inventory growth to retain the core user base.
Where Is It Heading?
Declining
The medication-reminder market is consolidating around specialized, hardware-integrated, or niche-focused trackers, leaving MyTherapy's generic approach vulnerable. Unless the team resolves the current notification instability and pivots away from aggressive ad-monetization, the app will continue to lose its most valuable chronic-condition users to more specialized rivals.
Notification failures following the latest update disrupt daily medication adherence, which directly erodes the app's primary value proposition and increases churn risk.
Intrusive advertising and subscription pressure alienate legacy users, causing a shift in sentiment that threatens the app's long-term retention metrics.
Recent updates focus exclusively on stability and bug fixes, indicating a lack of feature expansion to counter niche competitors like Shotsy.